Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lindauer, Eva ^a   Dupuis, Luc ^b,c   Müller, Hans Peter ^a   Neumann, Heiko ^a   Ludolph, Albert C ^a   Kassubek, Jan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Laboratoire des Mecanismes Centraux et Peripheriques de la Neurodegenerescence   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RATING SCALE; SEX DIFFERENCE; SUBCUTANEOUS FAT; SURVIVAL PREDICTION; CASE CONTROL STUDY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; SURVIVAL RATE;

AMYOTROPHIC LATERAL SCLEROSIS; BODY FAT DISTRIBUTION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; PROGNOSIS; SUBCUTANEOUS FAT; SURVIVAL RATE;

EID: 84879514688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067783     Document Type: Article

References (46)

1. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP, (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10: 75-82.
2. Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, et al. (2011) Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 82: 628-634.
3. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, et al. (1999) Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53: 1059-1063.
4. Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, et al. (2010) A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler.
5. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM, (2011) Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve 44: 20-24.
6. Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, et al. (2010) ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol.
7. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, et al. (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70: 1004-1009.
8. Dorst J, Kühnlein P, Hendrich C, Kassubek J, Sperfeld AD, et al. (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in Amyotrophic Lateral Sclerosis. J Neurol 258: 613-617.
9. Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, et al. (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11: 166-171.
10. Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, et al. (2013) Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort. Neurology 80: 829-838.
11. Mattson MP, Cutler RG, Camandola S, (2007) Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med 9: 17-20.
12. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP, (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101: 11159-11164.
13. Desport JC, Preux PM, Bouteloup-Demange C, Clavelou P, Beaufrere B, et al. (2003) Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 77: 1179-1185.
14. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C, (2003) Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107: 1626-1631.
15. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, et al. (2003) Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 77: 1192-1197.
16. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, et al. (1997) Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 5: 93-99.
17. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB, (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81: 555-563.
18. Tran TT, Yamamoto Y, Gesta S, Kahn CR, (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7: 410-420.
19. Müller HP, Raudies F, Unrath A, Neumann H, Ludolph AC, et al. (2011) Quantification of human body fat tissue percentage by MRI. NMR Biomed 24: 17-24.
20. Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, et al. (2000) Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 91-96.
21. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, et al. (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74: 328-334.
22. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, et al. (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256: 1236-1242.
23. Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, Rene F, et al. (2007) Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 48: 1571-1580.
24. Gorgey AS, Mather KJ, Poarch HJ, Gater DR, (2011) Influence of motor complete spinal cord injury on visceral and subcutaneous adipose tissue measured by multi-axial magnetic resonance imaging. J Spinal Cord Med 34: 99-109.
25. Nelson MD, Widman LM, Abresch RT, Stanhope K, Havel PJ, et al. (2007) Metabolic syndrome in adolescents with spinal cord dysfunction. J Spinal Cord Med 30Suppl 1: S127-139.
26. Edwards LA, Bugaresti JM, Buchholz AC, (2008) Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences. Am J Clin Nutr 87: 600-607.
27. Groah SL, Nash MS, Ljungberg IH, Libin A, Hamm LF, et al. (2009) Nutrient intake and body habitus after spinal cord injury: an analysis by sex and level of injury. J Spinal Cord Med 32: 25-33.
28. Sabour H, Javidan AN, Vafa MR, Shidfar F, Nazari M, et al. (2012) Calorie and macronutrients intake in people with spinal cord injuries: An analysis by sex and injury-related variables. Nutrition 28: 143-147.
29. Buchholz AC, Pencharz PB, (2004) Energy expenditure in chronic spinal cord injury. Curr Opin Clin Nutr Metab Care 7: 635-639.
30. Liusuwan A, Widman L, Abresch RT, McDonald CM, (2004) Altered body composition affects resting energy expenditure and interpretation of body mass index in children with spinal cord injury. J Spinal Cord Med 27Suppl 1: S24-28.
31. Liusuwan RA, Widman LM, Abresch RT, Styne DM, McDonald CM, (2007) Body composition and resting energy expenditure in patients aged 11 to 21 years with spinal cord dysfunction compared to controls: comparisons and relationships among the groups. J Spinal Cord Med 30Suppl 1: S105-111.
32. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ, (1996) Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 63: 130-137.
33. Gibbons ZC, Richardson A, Neary D, Snowden JS, (2008) Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9: 67-74.
34. Piguet O, Hornberger M, Mioshi E, Hodges JR, (2011) Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 10: 162-172.
35. Piguet O, Petersen A, Yin Ka Lam B, Gabery S, Murphy K, et al. (2011) Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol 69: 312-319.
36. Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, et al. (2002) betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297: 843-845.
37. Karlsborg M, Andersen EB, Wiinberg N, Gredal O, Jorgensen L, et al. (2003) Sympathetic dysfunction of central origin in patients with ALS. Eur J Neurol 10: 229-234.
38. Baltadzhieva R, Gurevich T, Korczyn AD, (2005) Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol 18: 487-493.
39. van der Burg JM, Bjorkqvist M, Brundin P, (2009) Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol 8: 765-774.
40. Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K, (2009) Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models. Hum Mol Genet 18: 1006-1016.
41. Fain JN, Del Mar NA, Meade CA, Reiner A, Goldowitz D, (2001) Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum Mol Genet 10: 145-152.
42. Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, et al. (2010) Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patients. Clin Endocrinol (Oxf) 73: 206-211.
43. Aziz NA, Pijl H, Frolich M, Snel M, Streefland TC, et al. (2010) Systemic energy homeostasis in Huntington's disease patients. J Neurol Neurosurg Psychiatry 81: 1233-1237.
44. Gamba P, Testa G, Sottero B, Gargiulo S, Poli G, et al. (2012) The link between altered cholesterol metabolism and Alzheimer's disease. Ann N Y Acad Sci 1259: 54-64.
45. Di Paolo G, Kim TW, (2011) Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci 12: 284-296.
46. Adibhatla RM, Hatcher JF, (2008) Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49: 241-268.